Evidence map›Paper›PMID 33807654›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Antibiotic Resistant Bloodstream Infections in Pediatric Patients Receiving Chemotherapy or Hematopoietic Stem Cell Transplant: Factors Associated with Development of Resistance, Intensive Care Admission and Mortality.

Elio Castagnola, Francesca Bagnasco, Alessio Mesini, Philipp K A Agyeman, Roland A Ammann, Fabianne Carlesse, Maria Elena Santolaya de Pablo, Andreas H Groll, Gabrielle M Haeusler, Thomas Lehrnbecher and 14 more

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Infections withJournal of clinical medicine · 2025
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 11 institutions in 8 countries.

Elio CastagnolaInfectious Diseases Unit, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.
Francesca BagnascoEpidemiology and Biostatistics Unit, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.ORCID 0000-0003-1601-9518
Alessio MesiniInfectious Diseases Unit, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.
Philipp K A AgyemanDepartment of Pediatrics, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.ORCID 0000-0002-8339-5444
Roland A AmmannPediatric Hematology/Oncology, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.ORCID 0000-0002-1902-2352
Fabianne CarlessePediatric Oncology Institute, GRAACC/Federal University of Sao Paulo, Sao Paulo 04023-062, Brazil.ORCID 0000-0001-7037-3425
Maria Elena Santolaya de PabloFacultad de Medicina, Universidad de Chile, Hospital Dr. Luis Calvo Mackenna, Santiago 7500539, Chile.
Andreas H GrollInfectious Disease Research Program, Center for Bone Marrow Transplantation and Department of Paediatric Haematology and Oncology, University Children's Hospital Muenster, 48149 Muenster, Germany.ORCID 0000-0003-1188-393X
Gabrielle M HaeuslerThe Paediatric Integrated Cancer Service, Parkville, VIC 3052, Australia.
Thomas LehrnbecherDivision of Pediatric Hematology and Oncology, Hospital for Children and Adolescents, University Hospital, Johann Wolfgang Goethe University, 60323 Frankfurt am Main, Germany.
Arne SimonPediatric Oncology and Hematology, Children's Hospital Medical Center, University Clinics, 6642 Homburg, Germany.ORCID 0000-0001-9558-3330
Maria Rosaria D'AmicoDepartment Hemato-Oncology, AORN Santobono-Pausilipon, 80129 Napoli, Italy.
Austin DuongChild Health Evaluative Sciences, The Hospital for Sick Children, Peter Gilgan Centre for Research & Learning, Toronto, ON M5G 0A4, Canada.
Evgeny A IdelevichInstitute of Medical Microbiology, University Hospital Munster, 48149 Munster, Germany.
Marie LuckowitschDivision of Pediatric Hematology and Oncology, Hospital for Children and Adolescents, University Hospital, Johann Wolfgang Goethe University, 60323 Frankfurt am Main, Germany.
Mariaclaudia MeliPediatric Hemato-Oncology Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.ORCID 0000-0002-7504-314X
Giuseppe MennaDepartment Hemato-Oncology, AORN Santobono-Pausilipon, 80129 Napoli, Italy.
Sasha PalmertChild Health Evaluative Sciences, The Hospital for Sick Children, Peter Gilgan Centre for Research & Learning, Toronto, ON M5G 0A4, Canada.
Giovanna RussoPediatric Hemato-Oncology Unit, Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.ORCID 0000-0001-9369-7473
Marco SarnoPediatric Unit, Santa Maria Delle Grazie Hospital, ASL Napoli 2 Nord, Pozzuoli, 80027 Napoli, Italy.
Galina SolopovaDmitry Rogachev Federal Scientific-Clinical Center of Children's Hematology, Oncology and Immunology, 117997 Moscow, Russia.
Annalisa TondoPaediatric Haematology/Oncology Department, Meyer Children's University Hospital, 50134 Florence, Italy.
Yona TraubiciChild Health Evaluative Sciences, The Hospital for Sick Children, Peter Gilgan Centre for Research & Learning, Toronto, ON M5G 0A4, Canada.
Lillian SungChild Health Evaluative Sciences, The Hospital for Sick Children, Peter Gilgan Centre for Research & Learning, Toronto, ON M5G 0A4, Canada.
Hospital for Sick Children · CAIstituto Giannina Gaslini · ITGoethe University Frankfurt · DEUniversity Hospital Münster · DEUniversity of Bern · CHUniversity of Catania · ITDmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology · RUHospital Luis Calvo Mackenna · CLMeyer Children's Hospital · ITSupport group for adolescents and children with cancer · BRThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bloodstream infections (BSI) are a severe complication of antineoplastic chemotherapy or hematopoietic stem cell transplantation (HSCT), especially in the presence of antibiotic resistance (AR). A multinational, multicenter retrospective study in patients aged ≤ 18 years, treated with chemotherapy or HSCT from 2015 to 2017 was implemented to analyze AR among non-common skin commensals BSI. Risk factors associated with AR, intensive care unit (ICU) admission and mortality were analyzed by multilevel mixed effects or standard logistic regressions. A total of 1291 BSIs with 1379 strains were reported in 1031 patients. Among Gram-negatives more than 20% were resistant to ceftazidime, cefepime, piperacillin-tazobactam and ciprofloxacin while 9% was resistant to meropenem. Methicillin-resistance was observed in 17% of

Indexed as

allogeneic stem cell transplantantibiotic resistancebloodstream infectionschemotherapyintensive care admission and mortalitypediatric patients

Identifiers

PMID33807654
PMCPMC8000765
OpenAlexW3134622860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.